Phase Ii Trial Of Rituximab As Adjuvant Therapy To High Dose Chemotherapy And Peripheral Blood Stem Cell Transplantation For Relapsed And Refractory Aggressive Non-Hodgkin'S Lymphomas.
BLOOD（2001）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined